Presbia Plc (LENS): Gerald Farrell , director of Presbia Plc purchased 5,000 shares on May 17, 2016. The Insider buying transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were purchased at $4.65 per share for a total value of $23,250.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Dec 18, 2015, Richard S Ressler (director 10% owner) purchased 500 shares at $6.00 per share price.On Nov 30, 2015, Randy H Thurman (Executive Chairman) purchased 1,833 shares at $5.45 per share price.Also, On Nov 23, 2015, Zohar Loshitzer (Chief Bus. Development Officer) purchased 5,500 shares at $4.00 per share price.On Nov 20, 2015, Robert J Cresci (director) purchased 10,000 shares at $3.97 per share price.
Presbia PLC (LENS) witnessed a volatile trading activity on Thursday May 19, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $4.77 and reached the intraday high at $4.9. The bulls started the profit booking and pushed the shares to intraday low of $4.53. The trading session was marked by a volume range of 6,780 shares exchanging hands. The 52-week high of the shares is $9.377 and the 52-week low is $2.94. The market cap of the company stands at $63,379 M and there are 13,37,10,00,000 shares in public circulation.
Company has been under the radar of several Street Analysts.Presbia PLC is Initiated by Rodman & Renshaw to Buy and the brokerage firm has set the Price Target at $14. The Rating was issued on May 10, 2016.
Presbia PLC is a development-stage ophthalmic device company. The Company has developed and is marketing an optical lens implant for treating presbyopia the age-related loss of the ability to focus on near objects. Its lens which it refers to as its microlens is a miniature lens designed to be surgically implanted in a patient’s eye for that patient’s ability to see objects at close distances. Its microlens procedure is performed using a 150 kilohertz femtosecond laser. In commercializing its solution it intends to focus those markets with a presence of refractive laser centers equipped with femtosecond lasers. The Presbia Flexivue Microlens is a solution for the common age-related loss of the ability to read or focus on near objects. The 3mm diameter lens is implanted in a corneal pocket created by a femtosecond laser. It offers a solution for people to read common items such as newspapers restaurant menus cell phone messages and supermarket labels without glasses.